Evaluation of the Relationship Between Mediterranean Diet and Menopausal Symptoms in Postmenopausal Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

305 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional study aimed to evaluate the relationship between the frequency and severity of postmenopausal symptoms in women aged 45-65 years and the level of compliance with the Mediterranean diet, and the main question it aimed to answer is: Do women with higher compliance with the Mediterranean diet have milder symptoms?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diet, Cardiometabolic Risk (CM) and Menopause Symptoms

NCT05764473

Metabolic Syndrome, Protection Against Menopause

COMPLETED NA

Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

NCT04424173

CRP Menopause

COMPLETED

Solution-focused Counseling for Menopausal Symptoms

NCT06582433

Menopause Menopause Related Conditions Menopausal Depression

COMPLETED NA

MHT and Liver Function in Postmenopausal Women

NCT07103603

Menopause Non Alcholic Fatty Liver Disease Hepatic Steatosis

COMPLETED NA

Metabotyping in the Postmenopausal Stage

NCT05397015

Menopause Postmenopausal Disorder Postmenopausal Symptoms

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This cross-sectional study was conducted between 01.01.2024 and 01.06.2024 with women aged 45-65 who were registered at Tuzla E-ASM affiliated with Marmara University Pendik Hospital and who had been in menopause for at least 1 year. The sample size was calculated as 272 and the target number was determined as 305. After obtaining written consent from the participants who agreed to participate in the study and met the inclusion criteria, a questionnaire form was applied to these individuals, which questioned their sociodemographic characteristics, age of menstruation onset, pregnancy history, smoking and alcohol use, use of supplements, Mediterranean Diet Adherence Scale (MEDAS) and Menopause Rating Scale (MRS). The presence, type and severity of menopausal symptoms with the Mediterranean diet were evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopausal Complaints

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

postmenopausal women aged 45-65

Women who were registered at Tuzla E-ASM affiliated with Marmara University Pendik Hospital and who had been in menopause for at least 1 year

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who volunteered to participate in the study,

Exclusion Criteria

* Those with a diagnosed eating disorder,
* Those using medication for obesity,
* Those with a chronic metabolic disease that is not receiving treatment and whose values related to the disease are not regulated (pronounced hypo/hyperthyroidism, uncontrolled diabetes, etc.),
* Those with a mental or physical condition that prevents communication (some neuropsychiatric diseases and mental retardation),
* Those who do not understand and/or speak Turkish,
* Those who do not give consent to participate in the study, •-Those who are currently using any hormonal supplements to prevent or reduce menopausal symptoms were excluded from the study.

Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes